|Awarded On||February 21, 2018|
|Title||DNA methylation signatures of cell-free DNA in CSF as a new response biomarker for pediatric medulloblastoma|
|Award Mechanism||Individual Investigator Research Awards for Cancer in Children and Adolescents|
|Institution/Organization||Texas A&M University System Health Science Center|
|Principal Investigator/Program Director||Deqiang Sun|
|Cancer Sites||Brain and Other Nervous System|
Brain tumors are the leading cause of cancer-related death in children. Current radiographic techniques to access treatment response, monitor disease progression, and detect early recurrence lack the desired sensitivity. There is an unmet need to provide physicians with improved methods (our proposed biomarker) to accurately and timely deliver the most optimal care to children with brain tumors. 'Liquid biopsy', based on the measurement of circulating particles such as DNA shed into blood or other biological fluid originated from tumor sites, is an important new technology to monitor the state of tumors without subjecting patients to direct biopsies of the tumor. The proposed studies invo...